Banzel is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Rufinamide.
Product ID | 62856-583_0ab0a8e5-ba46-496a-8f62-be8d95512d2d |
NDC | 62856-583 |
Product Type | Human Prescription Drug |
Proprietary Name | Banzel |
Generic Name | Rufinamide |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2008-11-14 |
Marketing Category | NDA / NDA |
Application Number | NDA021911 |
Labeler Name | Eisai Inc. |
Substance Name | RUFINAMIDE |
Active Ingredient Strength | 400 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-08-08 |
NDC Exclude Flag | N |
Sample Package? | Y |
Marketing Category | NDA |
Application Number | NDA021911 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2008-11-14 |
Marketing Category | NDA |
Application Number | NDA021911 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-08-08 |
Ingredient | Strength |
---|---|
RUFINAMIDE | 400 mg/1 |
SPL SET ID: | 0a3fa925-1abd-458a-bd57-4ae780a1ef2d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
62856-582 | Banzel | rufinamide |
62856-583 | Banzel | rufinamide |
62856-584 | Banzel | rufinamide |
68180-797 | Banzel | Rufinamide Oral Suspension |
0054-0425 | Rufinamide | Rufinamide |
0054-0426 | Rufinamide | Rufinamide |
0054-0528 | Rufinamide | Rufinamide |
0378-2330 | Rufinamide | rufinamide |
0378-2331 | Rufinamide | rufinamide |
31722-598 | Rufinamide | Rufinamide |
31722-599 | Rufinamide | Rufinamide |
59651-563 | RUFINAMIDE | RUFINAMIDE |
60687-643 | Rufinamide | Rufinamide |
67877-673 | Rufinamide | Rufinamide |
68180-802 | RUFINAMIDE | rufinamide |
68180-803 | RUFINAMIDE | rufinamide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BANZEL 77334627 3613307 Live/Registered |
Eisai R&D Management Co., Ltd. 2007-11-20 |